151 related articles for article (PubMed ID: 15701278)
21. Decline in corpus callosum volume among pediatric patients with medulloblastoma: longitudinal MR imaging study.
Palmer SL; Reddick WE; Glass JO; Gajjar A; Goloubeva O; Mulhern RK
AJNR Am J Neuroradiol; 2002 Aug; 23(7):1088-94. PubMed ID: 12169462
[TBL] [Abstract][Full Text] [Related]
22. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
Korah MP; Esiashvili N; Mazewski CM; Hudgins RJ; Tighiouart M; Janss AJ; Schwaibold FP; Crocker IR; Curran WJ; Marcus RB
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):106-12. PubMed ID: 19695790
[TBL] [Abstract][Full Text] [Related]
23. Differences in supratentorial damage of white matter in pediatric survivors of posterior fossa tumors with and without adjuvant treatment as detected by magnetic resonance diffusion tensor imaging.
Rueckriegel SM; Driever PH; Blankenburg F; Lüdemann L; Henze G; Bruhn H
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):859-66. PubMed ID: 19540067
[TBL] [Abstract][Full Text] [Related]
24. Boost Gamma Knife surgery during multimodality management of adult medulloblastoma.
Germanwala AV; Mai JC; Tomycz ND; Niranjan A; Flickinger JC; Kondziolka D; Lunsford LD
J Neurosurg; 2008 Feb; 108(2):204-9. PubMed ID: 18240913
[TBL] [Abstract][Full Text] [Related]
25. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Scantlebury N; Law N; Spiegler BJ; Malkin D; Janzen L; Mabbott D
J Clin Oncol; 2014 Jun; 32(17):1760-8. PubMed ID: 24516024
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal Sparing During Craniospinal Irradiation: What Did We Learn About the Incidence of Perihippocampus Metastases?
Padovani L; Chapon F; André N; Boucekine M; Geoffray A; Bourdeau F; Masliah-Planchon J; Claude L; Huchet A; Laprie A; Supiot S; Coche-Dequéant B; Kerr C; Alapetite C; Leseur J; Nguyen T; Chapet S; Bernier V; Bondiau PY; Noel G; Habrand JL; Bolle S; Doz F; Dufour C; Muracciole X; Carrie C
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):980-986. PubMed ID: 29485078
[TBL] [Abstract][Full Text] [Related]
27. A hybrid neural network analysis of subtle brain volume differences in children surviving brain tumors.
Reddick WE; Mulhern RK; Elkin TD; Glass JO; Merchant TE; Langston JW
Magn Reson Imaging; 1998 May; 16(4):413-21. PubMed ID: 9665552
[TBL] [Abstract][Full Text] [Related]
28. [Results of radiation therapy for medulloblastoma].
Shibamoto Y; Abe M; Tsutsui K; Ono K; Takahashi M
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2491-8. PubMed ID: 2614186
[TBL] [Abstract][Full Text] [Related]
29. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
[TBL] [Abstract][Full Text] [Related]
30. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
[TBL] [Abstract][Full Text] [Related]
31. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
32. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
[TBL] [Abstract][Full Text] [Related]
33. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
[TBL] [Abstract][Full Text] [Related]
34. Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: age-dependent effects of whole brain radiation.
Radcliffe J; Bunin GR; Sutton LN; Goldwein JW; Phillips PC
Int J Dev Neurosci; 1994 Jun; 12(4):327-34. PubMed ID: 7976487
[TBL] [Abstract][Full Text] [Related]
35. Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma.
Palmer SL; Gajjar A; Reddick WE; Glass JO; Kun LE; Wu S; Xiong X; Mulhern RK
Neuropsychology; 2003 Oct; 17(4):548-55. PubMed ID: 14599268
[TBL] [Abstract][Full Text] [Related]
36. Comparison of supine and prone craniospinal irradiation in children with medulloblastoma.
Verma J; Mazloom A; Teh BS; South M; Butler EB; Paulino AC
Pract Radiat Oncol; 2015; 5(2):93-8. PubMed ID: 25413414
[TBL] [Abstract][Full Text] [Related]
37. Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma.
Paulino AC; Mazloom A; Teh BS; South M; Okcu MF; Su J; Butler EB; Chintagumpala M
Cancer; 2011 Feb; 117(3):635-41. PubMed ID: 20845476
[TBL] [Abstract][Full Text] [Related]
38. Medulloblastoma: treatment results with radiation therapy.
Lowery GS; Ferree CR; Raben M
South Med J; 1981 Sep; 74(9):1047-9. PubMed ID: 7280749
[TBL] [Abstract][Full Text] [Related]
39. Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood.
Mulhern RK; White HA; Glass JO; Kun LE; Leigh L; Thompson SJ; Reddick WE
J Int Neuropsychol Soc; 2004 Mar; 10(2):180-9. PubMed ID: 15012838
[TBL] [Abstract][Full Text] [Related]
40. Intracerebral cavernous hemangioma after cranial irradiation in childhood. Incidence and risk factors.
Strenger V; Sovinz P; Lackner H; Dornbusch HJ; Lingitz H; Eder HG; Moser A; Urban C
Strahlenther Onkol; 2008 May; 184(5):276-80. PubMed ID: 18427759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
